GTgroup Farma

GT Biopharma, Inc. is a biotechnology company based in Brisbane, California, focused on developing innovative immuno-oncology therapies. The company specializes in harnessing the body's natural immune system, particularly natural killer (NK) cells, to target and eliminate cancer cells. GT Biopharma operates within the healthcare sector, specifically in medical diagnostics and pharmaceutical preparation manufacturing. The company has developed proprietary therapeutic platforms, including TriKE® technology, which creates targeted immunotherapeutic agents to enhance the selective killing of cancer cells. Their product pipeline includes novel biopharmaceutical drugs aimed at treating various cancers, such as acute lymphocytic leukemia and non-Hodgkin's lymphoma, currently in early-stage clinical trials. GT Biopharma's customers include healthcare providers, research institutions, and pharmaceutical partners involved in cancer treatment and immunotherapy development.

• Employees 11